Ligand Pharmaceuticals Inc (NASDAQ:LGND)

104.00
Delayed Data
As of Sep 20
 -0.69 / -0.66%
Today’s Change
84.45
Today|||52-Week Range
278.62
-23.36%
Year-to-Date
Ligand (LGND) Surges: Stock Moves 6.3% Higher
Sep 13 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close104.69
Today’s open104.70
Day’s range103.09 - 107.67
Volume982,986
Average volume (3 months)398,118
Market cap$2.0B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+1,034.54%
Earnings growth (this year)-54.27%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+78.21%
P/E ratio3.2
Price/Sales12.99
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.04+0.07%
AKCAAkcea Therapeutics I...-0.01-0.04%
ZGNXZogenix Inc+0.07+0.17%
AGIOAgios Pharmaceutical...+0.27+0.75%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateOctober 30, 2019
EPS forecast (this quarter)$0.61
Annual revenue (last year)$251.5M
Annual profit (last year)$143.3M
Net profit margin57.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts